ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Davis Select US Equity

Davis Select US Equity (DUSA)

45.54
0.00
(0.00%)
Closed February 05 4:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
45.54
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
37.0801 52 Week Range 45.91
Previous Close
45.54
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
46,413
Financial Volume
-
VWAP
-

DUSA Latest News

DUSA Pharmaceuticals, Inc.(R) to Host Fourth Quarter and Full Year 2009 Financial Results and Corporate Highlights Conference Ca

WILMINGTON, Mass., Feb. 26 /PRNewswire/ -- DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA) announces that its 2009 corporate highlights and year end financial results press release will be issued...

DUSA Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference

WILMINGTON, Mass., Feb. 2 PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (NASDAQ:DUSA), a specialty pharmaceutical company focused primarily on the development and marketing of its...

DUSA Pharmaceuticals to Present at the Merriman Curhan Ford Investor Summit 2009

WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and...

DUSA Pharmaceuticals Reports Third Quarter 2009 Corporate Highlights and Financial Results

Q3 Domestic PDT revenues up 32% year over year; Q3 Non-GAAP loss improves 86% year over year to ($0.2) million WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.®...

DUSA Pharmaceuticals Surpasses One Million in Cumulative Levulan(R) Kerastick(R) Sales Units

WILMINGTON, Mass., Oct. 28 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.® (Nasdaq GM: DUSA), a specialty pharmaceutical company focused on dermatology, announced today that global sales...

DUSA Pharmaceuticals Named to Deloitte's 2009 Technology Fast 500 List of Fastest Growing Companies in North America

Second Consecutive Year DUSA Has Been Recognized WILMINGTON, Mass., Oct. 21 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc.(R) (NASDAQ:DUSA), a specialty pharmaceutical company focused on...

DUSA Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

WILMINGTON, Mass., Sept. 2 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (NASDAQ:DUSA), a dermatology company that is developing and marketing Levulan Photodynamic Therapy (PDT) and...

DUSA Pharmaceuticals Reports Second Quarter 2009 Corporate Highlights and Financial Results

Q2 Domestic PDT revenues up 24% year over year; Kerastick margins reach a record high of 85% WILMINGTON, Mass., Aug. 11 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (NASDAQ GM: DUSA), a...

DUSA Pharmaceuticals, Inc.(R) Announces Second Quarter Financial Results and Corporate Highlights Conference Call

WILMINGTON, Mass., Aug. 6 /PRNewswire-FirstCall/ -- DUSA Pharmaceuticals, Inc. (Nasdaq GM: DUSA) announces that its corporate highlights and second quarter financial results press release will...

Amex to Trade Options on Nine Securities

Amex to Trade Options on Nine Securities NEW YORK, March 8 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) will launch trading in options on Tuesday, March 9, 2004, on the underlying...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.210.46326935804145.3345.9144.614338845.41661175SP
42.826.6011235955142.7245.9142.0077825695844.38941177SP
121.423.218495013644.1245.9141.774641343.94732296SP
268.0221.375266524537.5245.9137.53248342.89125202SP
528.1721.862456515937.3745.9137.08012989741.42244328SP
15610.9631.694621168334.5845.9124.672665034.21542033SP
26012.8239.180929095432.7245.9124.672445134.33413558SP

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
$ 16.84
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 74.2235
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.73
(0.00%)
0
AACGATA Creativity Global
$ 0.82
(0.00%)
0
AALAmerican Airlines Group Inc
$ 16.84
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 74.2235
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.73
(0.00%)
0
AACGATA Creativity Global
$ 0.82
(0.00%)
0
AALAmerican Airlines Group Inc
$ 16.84
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
$ 74.2235
(0.00%)
0
AADIAadi Bioscience Inc
$ 2.73
(0.00%)
0
AACGATA Creativity Global
$ 0.82
(0.00%)
0

Discussion

View Full Feed
nowwhat2 nowwhat2 5 minutes ago
https://investorshub.advfn.com/uimage/uploads/2025/2/5/vamecrace_@_3_5y_downgap_chan.jpg






https://investorshub.advfn.com/uimage/uploads/2025/2/5/w[jdhrace_@_4_5y_UPGAP_SUCKS.jpg
RACE
meshcan meshcan 8 minutes ago
$215M and with that only ELTP can be over $2 pps
ELTP
Stino2 Stino2 18 minutes ago
The following company's did a RS and have sunk very deep: BNGO, MULLEN, JAGX, ADAP, OCGN, NKLA etc....🤑
ADAP BNGO JAGX
Stino2 Stino2 23 minutes ago
25% I have left and also this company doesn't answer their mails!!😪
TNXP
Stino2 Stino2 24 minutes ago
We wil see today???
TNXP
Biotechotcguy Biotechotcguy 29 minutes ago
This is getting juicy!!!!!
DROR
infamous infamous 34 minutes ago
so much for compliance again. what a trap this is
GCTK
misterfishman misterfishman 36 minutes ago
Agreed.
IGPK
bbotcs bbotcs 41 minutes ago
al44: That should result in a lawsuit.
bbotcs bbotcs 43 minutes ago
lj: SMCI
Has it finally bottomed, or will it retest the recent low of $25 and change? Stay tuned.
Thank you for mentioning the AMD calls. Will check them out today (Wednesday).
AMD SMCI
leavetheguntakethecannolis leavetheguntakethecannolis 44 minutes ago
A reminder for all.

https://www.beam-med.com/

Brain

Epilepsy is the most prevalent serious neurologic condition in the world, affecting about 70 million people. Unfortunately, 30%-40% of those patients are afflicted with drug resistant epilepsy, meaning t
IPIX
muee88 muee88 45 minutes ago
You’re welcome, no problem at all
NWBO
p0 p0 45 minutes ago
World’s First Chikungunya Vaccine, IXCHIQ
Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®

Valneva Receives Marketing Authorization in the UK for the World’s First Chikungunya Vaccine, IXCHIQ®


February
VALN
bbotcs bbotcs 45 minutes ago
lj; mid-40s with a brisk breeze barely felt like the mid-30's!
bbotcs bbotcs 47 minutes ago
lj: Oil price was down on Tuesday morning but the big oil stocks were up!
DJPele DJPele 50 minutes ago
Much appreciated Muee! Although I did trust your initial post, it does help seeing it's full contents.
NWBO
CaptainObvious CaptainObvious 54 minutes ago
Something is, that's for sure
NWBO
zino zino 55 minutes ago
Great advice...if we get the right Quant Merger this will explode and could turn into a
potential Nasdaq uplisting...Just look at Rgti and its run Quant related and they're raising money so easily to the tune of 15O Million...was a penny stock few months back
GCAN
pgsd pgsd 59 minutes ago
Typical for anything related to DCVax lol

It is included in the list of Proposed 24-25 HC Drugs:

In the alphabetic order from the list it is listed as 'Brain cancer vaccine' which is then crossed out and Murcidencel is added...

https://investorshub.advfn
NWBO
muee88 muee88 60 minutes ago
Also, the Proposed 24-25 HC drug list is alphabetical, but Murcidencel is listed under the Bs because “Brain Cancer Vaccine” is crossed out and replaced with Murcidencel.
NWBO
TurboMountain96 TurboMountain96 60 minutes ago
Frankly, we are the original MEGA, Make Elite Great Again. We had that slogan long before Trump entered politics or plagiarized from Ronald Reagan, who originally started Make America Great Again. So to that end, maybe to support the stockholders, our MEGA, we’re going to build a wall of needle move
ELTP
RichieBoy RichieBoy 1 hour ago
Only stating the patently obvious here...

When AFFU's dilution stops, the share price contraction stops. Just that simple. I get a strong sense the company is intentionally stalling for that reason. Mike Balkin and AFFU's other board member(s?) don't want to waste material event comp
AFFU
OnTrack444 OnTrack444 1 hour ago

Is this your newest made pump account with a 122 followers on X?   😂   Total comedy 🎭 

How much do they pay you to pump bloated pigs because you cer
HMBL
muee88 muee88 1 hour ago
Unfortunately, I don’t know how to upload a screenshot to this antiquated website —it shouldn’t be this difficult. I can assure you I’m not lying. Also, an email can be faked too so I’m not really sure what a screenshot would tell you.

However, here’s essentially the full text of the
NWBO
123tom 123tom 1 hour ago
Steve, what you're saying about AVXL price movement not holding the support levels you'd expect... that's something I've watched AVXL do for 14 years. It's what I call the "bleeding down game". I always expect to see lower lows than we ought to see. Even in bullish upwave patterns.... the seller
AVXL